Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter ended September 30, 2018 after the market closes on Tuesday, October 23, 2018,
October 9, 2018
· 1 min read